Nancy Devlin : Citation Profile

Are you Nancy Devlin?

University of Melbourne (47% share)
University of Sheffield (47% share)
Office of Health Economics (6% share)

11

H index

12

i10 index

454

Citations

RESEARCH PRODUCTION:

48

Articles

50

Papers

4

Books

RESEARCH ACTIVITY:

   25 years (1994 - 2019). See details.
   Cites by year: 18
   Journals where Nancy Devlin has often published
   Relations with other researchers
   Recent citing documents: 80.    Total self citations: 56 (10.98 %)

MORE DETAILS IN:
ABOUT THIS REPORT:

   Permalink: http://citec.repec.org/pde347
   Updated: 2020-01-25    RAS profile: 2019-10-17    
   Missing citations? Add them    Incorrect content? Let us know

Relations with other researchers

Works with:

Shah, Koonal (18)

Feng, Yan (14)

Parkin, David (9)

Hampson, Grace (6)

Cole, Amanda (6)

Cubi-Molla, Patricia (5)

Rice, Nigel (4)

Karlsberg, Sarah (3)

Mott, David (3)

Zamora, Bernarda (3)

Karlsberg Schaffer, Sarah (3)

Garau, Martina (2)

Brazier, John (2)

O'Neill, Phill (2)

Authors registered in RePEc who have co-authored more than one work in the last five years with Nancy Devlin.

Is cited by:

Brazier, John (11)

Towse, Adrian (10)

Blankart, Katharina (10)

Brouwer, Werner (10)

Tsuchiya, Aki (10)

Siciliani, Luigi (10)

McCarthy, Ian (8)

Hernandez Alava, Monica (8)

Garau, Martina (7)

pudney, stephen (7)

Leidl, Reiner (7)

Cites to:

Shah, Koonal (48)

Parkin, David (39)

Tsuchiya, Aki (34)

Feng, Yan (32)

Brazier, John (17)

Rice, Nigel (16)

Roberts, Jennifer (10)

Appleby, John (8)

Claxton, Karl (7)

Sculpher, Mark (6)

ABELLAN-PERPIÑAN, JOSE-MARIA (6)

Main data

Where Nancy Devlin has published?

Journals with more than one article published# docs
Health Economics15
The European Journal of Health Economics10
PharmacoEconomics8
Health Policy4
Social Science & Medicine3
Applied Health Economics and Health Policy2

Working Papers Series with more than one paper published# docs
Research Papers / Office of Health Economics25
Working Papers / Department of Economics, City University London11
Consulting Reports / Office of Health Economics6
Working Papers / Centre for Health Economics, University of York5

Recent works citing Nancy Devlin (2019 and 2018)

YearTitle of citing document
2018Ageing and health-related quality of life: evidence from Catalonia (Spain). (2018). Sole-Auro, Aida ; Alcaiz, Manuela. In: Working Papers. RePEc:bak:wpaper:201801.

Full description at Econpapers || Download paper

2017Scoping review on social care economic evaluation methods. (2017). Sculpher, Mark ; Faria, Rita ; van den Berg, Bernard ; Edwards, Mary ; Baragula, Erin ; Isojarvi, Jaana ; Glanville, Julie ; Nolan, Kay ; Oaneill, Peter ; Weatherly, Helen . In: Working Papers. RePEc:chy:respap:150cherp.

Full description at Econpapers || Download paper

2017Good, better, best? A comprehensive comparison of healthcare providers’ performance: An application to physiotherapy practices in primary care. (2017). Steenhuis, Sander ; Portrait, France ; Koolman, Xander ; Groeneweg, Niels. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:12:p:1225-1232.

Full description at Econpapers || Download paper

2017Implementation of the 2013 amended Patients’ Rights Act in Norway: Clinical priority guidelines and access to specialised health care. (2017). Johansson, Kjell Arne ; Lindemark, Frode ; Herlofsen, Berit ; Nygaard, Elizabeth . In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:4:p:346-353.

Full description at Econpapers || Download paper

2017New decision-making processes for the pricing of health technologies in Japan: The FY 2016/2017 pilot phase for the introduction of economic evaluations. (2017). Shiroiwa, Takeru ; Takura, Tomoyuki ; Ikeda, Shunya ; Fukuda, Takashi. In: Health Policy. RePEc:eee:hepoli:v:121:y:2017:i:8:p:836-841.

Full description at Econpapers || Download paper

2018Competition in the off-patent medicine market in Spain: The national reference pricing system versus the regional system of tendering for outpatient prescription medicines in Andalusia. (2018). Casanova-Juanes, Julieta ; Espin-Balbino, Jaime ; Mestre-Ferrandiz, Jorge. In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:12:p:1310-1315.

Full description at Econpapers || Download paper

2018An exploratory case study of the impact of expanding cost-effectiveness analysis for second-line nivolumab for patients with squamous non-small cell lung cancer in Canada: Does it make a difference?. (2018). Shafrin, Jason ; Jansen, Jeroen ; Penrod, John R ; Hertel, Nadine ; Lees, Michael ; Villeneuve, Julie ; Brauer, Michelle ; Skornicki, Michelle. In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:6:p:607-613.

Full description at Econpapers || Download paper

2018Looking back and moving forward: On the application of proportional shortfall in healthcare priority setting in the Netherlands. (2018). van Exel, Job ; Brouwer, W. B. F., ; van Exel, N. J. A., ; Reckers-Droog, V T. In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:6:p:621-629.

Full description at Econpapers || Download paper

2018A multi-criteria decision approach for ranking unmet needs in healthcare. (2018). Cleemput, Irina ; Westhovens, Rene ; Kohn, Laurence ; Devriese, Stephan . In: Health Policy. RePEc:eee:hepoli:v:122:y:2018:i:8:p:878-884.

Full description at Econpapers || Download paper

2019What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries. (2019). Cairns, John ; Maynou, Laia. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:130-139.

Full description at Econpapers || Download paper

2019Using a stated preference discrete choice experiment to assess societal value from the perspective of decision-makers in Europe. Does it work for rare diseases?. (2019). Trapero-Bertran, M ; Aranda-Reneo, I ; Ramos-Goi, J M ; Lopez-Bastida, J ; Martin, Rodriguez B ; Kanavos, P. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:152-158.

Full description at Econpapers || Download paper

2019Questioning the differences between general public vs. patient based preferences towards EQ-5D-5L defined hypothetical health states. (2019). Rupel, Valentina Prevolnik ; Fernandez, Natacha Bolanos ; Murovec, Nika ; Ogorevc, Marko. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:2:p:166-172.

Full description at Econpapers || Download paper

2019Geographic variation in inpatient costs for Acute Myocardial Infarction care: Insights from Italy. (2019). Nuti, Sabina ; Berta, Paolo ; Seghieri, Chiara. In: Health Policy. RePEc:eee:hepoli:v:123:y:2019:i:5:p:449-456.

Full description at Econpapers || Download paper

2017Values for the ICECAP-Supportive Care Measure (ICECAP-SCM) for use in economic evaluation at end of life. (2017). Huynh, Elisabeth ; Flynn, Terry ; Kinghorn, Philip ; Rose, John ; Coast, Joanna. In: Social Science & Medicine. RePEc:eee:socmed:v:189:y:2017:i:c:p:114-128.

Full description at Econpapers || Download paper

2018Integrating social justice concerns into economic evaluation for healthcare and public health: A systematic review. (2018). Dukhanin, Vadim ; Merritt, Maria W ; Taylor, Holly A ; Dowdy, David W ; Zwerling, Alice ; Searle, Alexandra. In: Social Science & Medicine. RePEc:eee:socmed:v:198:y:2018:i:c:p:27-35.

Full description at Econpapers || Download paper

2018Are life-extending treatments for terminal illnesses a special case? Exploring choices and societal viewpoints. (2018). van Exel, Job ; Baker, Rachel ; Donaldson, Cam ; Collins, Marissa ; Godwin, Jon ; Mason, Helen ; McHugh, Neil. In: Social Science & Medicine. RePEc:eee:socmed:v:198:y:2018:i:c:p:61-69.

Full description at Econpapers || Download paper

2018Institutional racism in public health contracting: Findings of a nationwide survey from New Zealand. (2018). Came, H ; McCreanor, T ; McKenna, B ; Doole, C. In: Social Science & Medicine. RePEc:eee:socmed:v:199:y:2018:i:c:p:132-139.

Full description at Econpapers || Download paper

2018Valuing health at the end of life: A review of stated preference studies in the social sciences literature. (2018). Tsuchiya, Aki ; Shah, Koonal ; Wailoo, Allan J. In: Social Science & Medicine. RePEc:eee:socmed:v:204:y:2018:i:c:p:39-50.

Full description at Econpapers || Download paper

2018Using path analysis to investigate the relationships between standardized instruments that measure health-related quality of life, capability wellbeing and subjective wellbeing: An application in the . (2018). Engel, Lidia ; David, ; Noonan, Vanessa K ; Bryan, Stirling. In: Social Science & Medicine. RePEc:eee:socmed:v:213:y:2018:i:c:p:154-164.

Full description at Econpapers || Download paper

2019How can we evaluate the cost-effectiveness of health system strengthening? A typology and illustrations. (2019). Hauck, Katharina ; Culyer, Anthony ; Vassall, A ; Thomas, R ; Over, M ; Meacock, R ; Levin, C ; Chi, Y-Ling ; Chalkidou, K ; Smith, P C ; Morton, A ; Verguet, S. In: Social Science & Medicine. RePEc:eee:socmed:v:220:y:2019:i:c:p:141-149.

Full description at Econpapers || Download paper

2019A comparison of professional and private time preferences of General Practitioners. (2019). Phimister, Euan ; van der Pol, Marjon ; Irvine, Alastair. In: Social Science & Medicine. RePEc:eee:socmed:v:222:y:2019:i:c:p:256-264.

Full description at Econpapers || Download paper

2018Reputations count: why benchmarking performance is improving health care across the world. (2018). Evans, Alice ; Bevan, Gwyn. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:86469.

Full description at Econpapers || Download paper

2018What is driving HTA decision-making? Evidence from cancer drug reimbursement decisions from 6 European countries. (2018). Cairns, John ; Maynou, Laia. In: LSE Research Online Documents on Economics. RePEc:ehl:lserod:90877.

Full description at Econpapers || Download paper

2018Can Pension Funds Partially Manage Longevity Risk by Investing in a Longevity Megafund?. (2018). Debonneuil, Edouard ; Planchet, Frederic ; Eyraud-Loisel, Anne. In: Risks. RePEc:gam:jrisks:v:6:y:2018:i:3:p:67-:d:155814.

Full description at Econpapers || Download paper

2018Do We Know What We Are Doing? An Exploratory Study on Swedish Health Economists and the EQ-5D. (2018). Gerdtham, Ulf-G. ; Tinghog, Gustav ; Gerdtham , Ulf-G., ; Gerdtham, Ulf-G., ; Lyttkens, Carl Hampus. In: Working Papers. RePEc:hhs:lunewp:2018_040.

Full description at Econpapers || Download paper

2018“Ageing and health-related quality of life: evidence from Catalonia (Spain)”. (2018). Sole-Auro, Aida ; Alcaiz, Manuela. In: IREA Working Papers. RePEc:ira:wpaper:201802.

Full description at Econpapers || Download paper

2018Education and health: welfare state composition and growth across country groups. (2018). Simões, Marta ; Andrade, João. In: Eastern Journal of European Studies. RePEc:jes:journl:y:2018:v:9:p:111-144.

Full description at Econpapers || Download paper

2017Rationing in health care provision: a welfare approach. (2017). LEVAGGI, ROSELLA. In: International Journal of Health Economics and Management. RePEc:kap:ijhcfe:v:17:y:2017:i:2:d:10.1007_s10754-016-9209-1.

Full description at Econpapers || Download paper

2017Risking the Sustainability of the Public Health System: Ethical Conundrums and Ideologically Embedded Reform. (2017). Brunton, Margaret . In: Journal of Business Ethics. RePEc:kap:jbuset:v:142:y:2017:i:4:d:10.1007_s10551-016-3041-x.

Full description at Econpapers || Download paper

2018Treatment Effects with Multiple Outcomes. (2018). Mullahy, John. In: NBER Working Papers. RePEc:nbr:nberwo:25307.

Full description at Econpapers || Download paper

2017How can HTA meet the needs of health system and government decision makers?. (2017). Towse, Adrian ; Hampson, Grace ; Henshall, C. In: Briefings. RePEc:ohe:briefg:001836.

Full description at Econpapers || Download paper

2017Transferability of HTA. (2017). Towse, Adrian ; Hampson, Grace ; Henshall, C ; Barnsley, P. In: Briefings. RePEc:ohe:briefg:001837.

Full description at Econpapers || Download paper

2017Policy Options for Formulary Development in Middle-income Countries. (2017). Towse, Adrian ; Garau, Martina ; Grewal, S ; Garrison, L ; Hernandez-Villafuerte, K. In: Consulting Reports. RePEc:ohe:conrep:001784.

Full description at Econpapers || Download paper

2018Appraising Ultra-Orphan Drugs: Is Cost-Per-QALY Appropriate? A Review of the Evidence. (2018). Towse, Adrian ; Garau, Martina. In: Consulting Reports. RePEc:ohe:conrep:001978.

Full description at Econpapers || Download paper

2019The WHO Technical Report on the Pricing of Cancer Medicines: Missing a central role for HTA and value assessment. (2019). Brassel, Simon ; Towse, A ; Rozanova, O. In: Research Papers. RePEc:ohe:respap:002154.

Full description at Econpapers || Download paper

2018The TRIPS Article 31 Tug of War Developing Country Compulsory Licensing of Pharmaceutical Patents and Developed Country Retaliation. (2018). Volman, Lucas. In: LawArXiv. RePEc:osf:lawarx:6cxaj.

Full description at Econpapers || Download paper

2019.

Full description at Econpapers || Download paper

2017Challenges in the Measurement of Public Sector Productivity in OECD 180 Countries. (2017). Edwin, Zsuzsanna Lonti ; Schultz, Rebecca . In: International Productivity Monitor. RePEc:sls:ipmsls:v:32:y:2017:10.

Full description at Econpapers || Download paper

2017Cost-Effectiveness Models in Breast Cancer Screening in the General Population: A Systematic Review. (2017). Schiller-Fruhwirth, Irmgard C ; Siebert, Uwe ; Arvandi, Marjan ; Jahn, Beate . In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:3:d:10.1007_s40258-017-0312-3.

Full description at Econpapers || Download paper

2017Decision Making and Priority Setting: The Evolving Path Towards Universal Health Coverage. (2017). Paolucci, Francesco ; Fiorentini, Gianluca ; Fouda, Ayman ; Redekop, Ken. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:15:y:2017:i:6:d:10.1007_s40258-017-0349-3.

Full description at Econpapers || Download paper

2018Towards a Transparent, Credible, Evidence-Based Decision-Making Process of New Drug Listing on the Hong Kong Hospital Authority Drug Formulary: Challenges and Suggestions. (2018). Ho, Carlos King ; Bernard, ; Wu, Olivia. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:1:d:10.1007_s40258-017-0339-5.

Full description at Econpapers || Download paper

2018Multiple Criteria Decision Analysis in Health Technology Assessment for Drugs: Just Another Illusion?. (2018). Garattini, Livio ; Padula, Anna. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:16:y:2018:i:1:d:10.1007_s40258-017-0345-7.

Full description at Econpapers || Download paper

2019Assessment of Devices, Diagnostics and Digital Technologies: A Review of NICE Medical Technologies Guidance. (2019). Crispi, Francisca ; Mossialos, Elias ; Osipenko, Leeza ; Barkauskaite, Eva ; Naci, Huseyin. In: Applied Health Economics and Health Policy. RePEc:spr:aphecp:v:17:y:2019:i:2:d:10.1007_s40258-018-0438-y.

Full description at Econpapers || Download paper

2018Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries. (2018). Angelis, Aris ; Kanavos, Panos ; Lange, Ansgar . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:1:d:10.1007_s10198-017-0871-0.

Full description at Econpapers || Download paper

2018New findings from the time trade-off for income approach to elicit willingness to pay for a quality adjusted life year. (2018). Attema, Arthur ; Exel, Job ; Krol, Marieke . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:2:d:10.1007_s10198-017-0883-9.

Full description at Econpapers || Download paper

2018Cost-effectiveness of different strategies to prevent breast and ovarian cancer in German women with a BRCA 1 or 2 mutation. (2018). Muller, Dirk ; Stock, Stephanie ; Schmutzler, Rita ; Borsi, Lisa ; Rasche, Linda ; Engel, Christoph ; Stollenwerk, Bjorn ; Rhiem, Kerstin ; Danner, Marion. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:3:d:10.1007_s10198-017-0887-5.

Full description at Econpapers || Download paper

2018Autonomy and performance in the public sector: the experience of English NHS hospitals. (2018). goddard, maria ; Jacobs, Rowena ; Verzulli, Rossella. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:4:d:10.1007_s10198-017-0906-6.

Full description at Econpapers || Download paper

2018Investigating the relationship between costs and outcomes for English mental health providers: a bi-variate multi-level regression analysis. (2018). Moran, Valerie ; Jacobs, Rowena. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:5:d:10.1007_s10198-017-0915-5.

Full description at Econpapers || Download paper

2018A comparison of the responsiveness of EQ-5D-5L and the QOLIE-31P and mapping of QOLIE-31P to EQ-5D-5L in epilepsy. (2018). , Ben ; McCrone, Paul ; Silvia, ; Ridsdale, Leone ; Mosweu, Iris . In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:6:d:10.1007_s10198-017-0928-0.

Full description at Econpapers || Download paper

2018The effectiveness and cost-effectiveness of plant sterol or stanol-enriched functional foods as a primary prevention strategy for people with cardiovascular disease risk in England: a modeling study. (2018). Yang, Wei ; RAATS, MONIQUE ; Jackson, Daniel ; Gage, Heather. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:7:d:10.1007_s10198-017-0934-2.

Full description at Econpapers || Download paper

2018What should we know about the person behind a TTO?. (2018). Nooten, Floortje ; Brouwer, Werner ; Exel, Job ; Agthoven, Michel ; Busschbach, Jan. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:19:y:2018:i:9:d:10.1007_s10198-018-0975-1.

Full description at Econpapers || Download paper

2019Are cost differences between specialist and general hospitals compensated by the prospective payment system?. (2019). Street, Andrew ; Siciliani, Luigi ; Longo, Francesco. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-017-0935-1.

Full description at Econpapers || Download paper

2019Future unrelated medical costs need to be considered in cost effectiveness analysis. (2019). Brouwer, Werner ; Meltzer, David ; Morton, Alec ; Baal, Pieter. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:1:d:10.1007_s10198-018-0976-0.

Full description at Econpapers || Download paper

2019Mapping health-related quality of life scores from FACT-G, FAACT, and FACIT-F onto preference-based EQ-5D-5L utilities in non-small cell lung cancer cachexia. (2019). Meregaglia, Michela ; Tarricone, Rosanna ; Cairns, John ; Borsoi, Ludovica. In: The European Journal of Health Economics. RePEc:spr:eujhec:v:20:y:2019:i:2:d:10.1007_s10198-017-0930-6.

Full description at Econpapers || Download paper

2018Predicting EuroQoL 5 Dimensions 5 Levels (EQ-5D-5L) Utilities from Older People’s Quality of Life Brief Questionnaire (OPQoL-Brief) Scores. (2018). Kaambwa, Billingsley ; Ratcliffe, Julie. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:1:d:10.1007_s40271-017-0259-3.

Full description at Econpapers || Download paper

2018Assessing the Use of a Feedback Module to Model EQ-5D-5L Health States Values in Hong Kong. (2018). , Eliza ; Rivero-Arias, Oliver ; Ramos-Goi, Juan Manuel. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:2:d:10.1007_s40271-017-0278-0.

Full description at Econpapers || Download paper

2018Incorporating Quantitative Patient Preference Data into Healthcare Decision Making Processes: Is HTA Falling Behind?. (2018). Mott, David. In: The Patient: Patient-Centered Outcomes Research. RePEc:spr:patien:v:11:y:2018:i:3:d:10.1007_s40271-018-0305-9.

Full description at Econpapers || Download paper

2017Does the Public Prefer Health Gain for Cancer Patients? A Systematic Review of Public Views on Cancer and its Characteristics. (2017). Morrell, Liz ; Barker, Richard ; Rees, Sian ; Wordsworth, Sarah . In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:8:d:10.1007_s40273-017-0511-7.

Full description at Econpapers || Download paper

2017Distribution-Weighted Cost-Effectiveness Analysis Using Lifetime Health Loss. (2017). , Ulrikke ; Norheim, Ole F ; Ottersen, Trygve ; Johansson, Kjell A. In: PharmacoEconomics. RePEc:spr:pharme:v:35:y:2017:i:9:d:10.1007_s40273-017-0524-2.

Full description at Econpapers || Download paper

2018The Future of Precision Medicine: Potential Impacts for Health Technology Assessment. (2018). Love-Koh, James ; Taylor, Matthew ; Wood, Hannah ; Chalkidou, Anastasia ; Manca, Andrea ; Lovett, Rosemary ; Ennis, Kate ; Rejon-Parrilla, Juan Carlos ; Peel, Alison. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:12:d:10.1007_s40273-018-0686-6.

Full description at Econpapers || Download paper

2018Estimating the Reference Incremental Cost-Effectiveness Ratio for the Australian Health System. (2018). Edney, Laura Catherine ; Karnon, Jonathan ; Cheng, Terence Chai ; Ali, Hossein Haji. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:2:d:10.1007_s40273-017-0585-2.

Full description at Econpapers || Download paper

2018Revealed and Stated Preferences of Decision Makers for Priority Setting in Health Technology Assessment: A Systematic Review. (2018). Lancsar, Emily ; Gu, Yuanyuan ; Zavarsek, Silva ; Ghijben, Peter . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:3:d:10.1007_s40273-017-0586-1.

Full description at Econpapers || Download paper

2018The Relative Importance of Clinical, Economic, Patient Values and Feasibility Criteria in Cancer Drug Reimbursement in Canada: A Revealed Preferences Analysis of Recommendations of the Pan-Canadian On. (2018). Skedgel, Chris ; Hu, Min ; Wranik, Dominika. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:4:d:10.1007_s40273-018-0610-0.

Full description at Econpapers || Download paper

2018Cost-Effectiveness Thresholds: the Past, the Present and the Future. (2018). Thokala, Praveen ; Tong, Thaison ; Leech, Ashley A ; Ochalek, Jessica. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:5:d:10.1007_s40273-017-0606-1.

Full description at Econpapers || Download paper

2018German Value Set for the EQ-5D-5L. (2018). Ludwig, Kristina ; Greiner, Wolfgang ; von der Schulenburg, J-Matthias Graf ; J-Matthias Graf von der Schulenburg, . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0615-8.

Full description at Econpapers || Download paper

2018Is EQ-5D-5L Better Than EQ-5D-3L? A Head-to-Head Comparison of Descriptive Systems and Value Sets from Seven Countries. (2018). Janssen, Mathieu F ; Luo, Nan ; Bonsel, Gouke J. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0623-8.

Full description at Econpapers || Download paper

2018A Systematic Review of Studies Comparing the Measurement Properties of the Three-Level and Five-Level Versions of the EQ-5D. (2018). Buchholz, Ines ; Feng, You-Shan ; Kohlmann, Thomas ; Janssen, Mathieu F. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0642-5.

Full description at Econpapers || Download paper

2018Head-to-Head Comparison of EQ‐5D‐3L and EQ‐5D‐5L Health Values. (2018). Selivanova, Anna ; Buskens, Erik . In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:6:d:10.1007_s40273-018-0647-0.

Full description at Econpapers || Download paper

2018A Practical Guide to Conducting a Systematic Review and Meta-analysis of Health State Utility Values. (2018). Petrou, Stavros ; Madan, Jason ; Kwon, Joseph. In: PharmacoEconomics. RePEc:spr:pharme:v:36:y:2018:i:9:d:10.1007_s40273-018-0670-1.

Full description at Econpapers || Download paper

2019The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals. (2019). pudney, stephen ; Wailoo, Allan ; Hernandez-Alava, Monica ; Pennington, Becky. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:1:d:10.1007_s40273-018-0701-y.

Full description at Econpapers || Download paper

2019One Method, Many Methodological Choices: A Structured Review of Discrete-Choice Experiments for Health State Valuation. (2019). Mulhern, Brendan ; Viney, Rosalie ; Street, Deborah J ; Norman, Richard. In: PharmacoEconomics. RePEc:spr:pharme:v:37:y:2019:i:1:d:10.1007_s40273-018-0714-6.

Full description at Econpapers || Download paper

2017Methodological Issues in Economic Evaluations Submitted to the Pan-Canadian Oncology Drug Review (pCODR). (2017). Masucci, Lisa ; Hoch, Jeffrey S ; Sabharwal, Mona ; Beca, Jaclyn. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0018-3.

Full description at Econpapers || Download paper

2017Statistical Alchemy: Conceptual Validity and Mapping to Generate Health State Utility Values. (2017). Round, Jeff ; Hawton, Annie. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:1:y:2017:i:4:d:10.1007_s41669-017-0027-2.

Full description at Econpapers || Download paper

2018An Exploratory Study of Long-Term Publicly Waitlisted Bariatric Surgery Patients’ Quality of Life Before and 1 Year After Bariatric Surgery, and Considerations for Healthcare Planners. (2018). Campbell, Julie A ; Palmer, Andrew J ; Wilkinson, Stephen ; Venn, Alison ; Neil, Amanda ; Hensher, Martin. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:1:d:10.1007_s41669-017-0038-z.

Full description at Econpapers || Download paper

2018Does Methodological Guidance Produce Consistency? A Review of Methodological Consistency in Breast Cancer Utility Value Measurement in NICE Single Technology Appraisals. (2018). Rose, Micah ; Craig, Dawn ; Rice, Stephen. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:2:d:10.1007_s41669-017-0040-5.

Full description at Econpapers || Download paper

2018Evaluation of Health Status of Type 2 Diabetes Outpatients Receiving Care in a Tertiary Hospital in Nigeria. (2018). Adibe, Maxwell Ogochukwu ; Isah, Abdulmuminu ; Nduka, Sunday Odunke ; Anosike, Chibueze. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-017-0056-x.

Full description at Econpapers || Download paper

2018Developing Accessible, Pictorial Versions of Health-Related Quality-of-Life Instruments Suitable for Economic Evaluation: A Report of Preliminary Studies Conducted in Canada and the United Kingdom. (2018). David, ; Hoch, Jeffrey S ; Victor, Charles J ; Simmons-Mackie, Nina ; Palmer, Rebecca ; Kagan, Aura ; Latimer, Nicholas R. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:2:y:2018:i:3:d:10.1007_s41669-018-0083-2.

Full description at Econpapers || Download paper

2019Conducting a Time Trade-Off Study Alongside a Clinical Trial: A Case Study and Recommendations. (2019). Pickard, Rob ; Vale, Luke ; Breckons, Matthew ; Mott, David ; Hill, Sarah ; Shen, Jing. In: PharmacoEconomics - Open. RePEc:spr:pharmo:v:3:y:2019:i:1:d:10.1007_s41669-018-0084-1.

Full description at Econpapers || Download paper

2018Empirical Comparison Between Capability and Two Health-Related Quality of Life Measures. (2018). Chen, Gang ; Richardson, Jeff ; McCaffrey, Nikki ; Kaambwa, Billingsley ; Ratcliffe, Julie. In: Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement. RePEc:spr:soinre:v:140:y:2018:i:1:d:10.1007_s11205-017-1788-9.

Full description at Econpapers || Download paper

Works by Nancy Devlin:

YearTitleTypeCited
1995Comment: Financing New Zealand’s Tertiary Education: How Much Subsidy? In: Agenda - A Journal of Policy Analysis and Reform.
[Full Text][Citation analysis]		article0
1994The effects of denturism: New Zealand dentists response to competition In: American Journal of Public Health.
[Citation analysis]		article0
2000The health state preferences and logistical inconsistencies of New Zealanders: a tale of two tariffs In: Working Papers.
[Full Text][Citation analysis]		paper1
2011Truly inefficient or providing better quality of care? Analysing the relationship between riskadjusted hospital costs and patients’ health outcomes In: Working Papers.
[Full Text][Citation analysis]		paper12
2013TRULY INEFFICIENT OR PROVIDING BETTER QUALITY OF CARE? ANALYSING THE RELATIONSHIP BETWEEN RISK‐ADJUSTED HOSPITAL COSTS AND PATIENTS HEALTH OUTCOMES.(2013) In: Health Economics.
[Citation analysis]
This paper has another version. Agregated cites: 12		article
2012Analysing Hospital Variation in Health Outcome at the Level of EQ-5D Dimensions In: Working Papers.
[Full Text][Citation analysis]		paper3
2013Methods for the estimation of the NICE cost effectiveness threshold In: Working Papers.
[Full Text][Citation analysis]		paper27
2013The influence of cost-effectiveness and other factors on NICE decisions In: Working Papers.
[Full Text][Citation analysis]		paper22
2013The Influence of Cost-effectiveness and Other Factors on NICE Decisions.(2013) In: Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 22		paper
2015The Influence of Cost‐Effectiveness and Other Factors on Nice Decisions.(2015) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 22		article
2003Does NICE have a cost effectiveness threshold and what other factors influence its decisions? A discrete choice analysis In: Working Papers.
[Full Text][Citation analysis]		paper3
2004Is there a case for using Visual Analogue Scale valuations in Cost-Utility Analysis? In: Working Papers.
[Full Text][Citation analysis]		paper18
2006Is there a case for using visual analogue scale valuations in cost-utility analysis?.(2006) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 18		article
2004A theoretical framework for TTO valuations and a taxonomy of TTO approaches: results from a pilot study In: Working Papers.
[Full Text][Citation analysis]		paper0
2005Understanding individuals’ decisions about vaccination: a comparison between Expected Utility and Regret Theory models In: Working Papers.
[Full Text][Citation analysis]		paper0
2006The impact of government targets on waiting times for elective surgery: new insights from time-to-event analysis In: Working Papers.
[Full Text][Citation analysis]		paper0
2008A note on the nature of utility in time and health and implications for cost utility analysis In: Working Papers.
[Full Text][Citation analysis]		paper3
2009A note on the nature of utility in time and health and implications for cost utility analysis.(2009) In: Social Science & Medicine.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 3		article
2008Statistical analysis of EQ-5D profiles: does the use of value sets bias inference? In: Working Papers.
[Full Text][Citation analysis]		paper5
2009Using the EQ-5D as a performance measurement tool in the NHS In: Working Papers.
[Full Text][Citation analysis]		paper2
2009Does the value of quality of life depend on duration? In: Working Papers.
[Full Text][Citation analysis]		paper1
2009A uniform Time Trade Off method for states better and worse than dead: feasibility study of the ‘lead time’ approach In: Working Papers.
[Full Text][Citation analysis]		paper15
2011A uniform time trade off method for states better and worse than dead: feasibility study of the ‘lead time’ approach.(2011) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 15		article
2013A Study of the Relationship Between Health and Subjective Well-being in Parkinson’s Disease Patients In: Working Papers.
[Full Text][Citation analysis]		paper2
2013A Study of the Relationship Between Health and Subjective Well-being in Parkinsons Disease Patients.(2013) In: Research Papers.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 2		paper
2015Local health care expenditure plans and their opportunity costs In: Health Policy.
[Full Text][Citation analysis]		article2
1996The cost-effectiveness of mammography screening: evidence from a microsimulation model for New Zealand In: Health Policy.
[Full Text][Citation analysis]		article5
2006Yes, No or Yes, but? Multinomial modelling of NICE decision-making In: Health Policy.
[Full Text][Citation analysis]		article7
2009Searching for cost effectiveness thresholds in the NHS In: Health Policy.
[Full Text][Citation analysis]		article12
1999The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule In: Social Science & Medicine.
[Full Text][Citation analysis]		article2
2005Continuity through change: The rhetoric and reality of health reform in New Zealand In: Social Science & Medicine.
[Full Text][Citation analysis]		article9
2009Identifying the impact of government targets on waiting times in the NHS In: Health Care Management Science.
[Full Text][Citation analysis]		article28
2000Allocating Vote: Health — ‘Needs Assessment’ and an Economics-Based Approach In: Treasury Working Paper Series.
[Full Text][Citation analysis]		paper0
2016New Age Decision Making in HTA: Is It Applicable in Asia? In: Briefings.
[Full Text][Citation analysis]		paper0
2012Time Trends in NICE HTA Decisions In: Consulting Reports.
[Full Text][Citation analysis]		paper0
2011The Evolution of HTA in Emerging Markets Health Care Systems: Analysis to Support a Policy Response In: Consulting Reports.
[Full Text][Citation analysis]		paper5
2015Do Respondents Completing Abstract, Hypothetical Priority-setting Exercises Agree With the Policy Implications of Their Choices? In: Consulting Reports.
[Full Text][Citation analysis]		paper3
2016Shaping the Research Agenda to Estimate Cost-effectiveness Thresholds for Decision Making In: Consulting Reports.
[Full Text][Citation analysis]		paper1
2018Quality of Life in Long-term Cancer Survivors: Implications for Future Health Technology Assessments in Oncology In: Consulting Reports.
[Full Text][Citation analysis]		paper0
2019Public Preferences for Health Gains and Cures: A Discrete Choice Experiment In: Consulting Reports.
[Full Text][Citation analysis]		paper0
2011Incorporating Multiple Criteria in HTA: Methods and Processes In: Monographs.
[Full Text][Citation analysis]		book19
2010Getting the Most out of PROMs: Putting Health Outcomes at the Heart of NHS Decision-Making In: Monographs.
[Full Text][Citation analysis]		book4
2002Cost-Effectiveness Thresholds: Economic and ethical issues In: Monographs.
[Full Text][Citation analysis]		book11
2004How Much Should We Spend on the NHS? In: Monographs.
[Full Text][Citation analysis]		book1
2013Searching for Cost-effectiveness Thresholds in NHS Scotland In: Research Papers.
[Full Text][Citation analysis]		paper0
2012Understanding Social Preferences Regarding the Prioritisation of Treatments Addressing Unmet Need and Severity In: Research Papers.
[Full Text][Citation analysis]		paper3
2012Assessing the Performance of the EQ-VAS in the NHS PROMs Programme In: Research Papers.
[Full Text][Citation analysis]		paper0
2011Operationalising Value Based Pricing of Medicines: A Taxonomy of Approaches In: Research Papers.
[Full Text][Citation analysis]		paper1
2011Is the Aim of the Health Care System to Maximise QALYs? An Investigation of In: Research Papers.
[Full Text][Citation analysis]		paper0
2010A Comparison of Alternative Variants of the Lead and Lag Time TTO In: Research Papers.
[Full Text][Citation analysis]		paper8
2013A COMPARISON OF ALTERNATIVE VARIANTS OF THE LEAD AND LAG TIME TTO.(2013) In: Health Economics.
[Citation analysis]
This paper has another version. Agregated cites: 8		article
2014Opportunity Costs of Implementing NICE Decisions in NHS Wales In: Research Papers.
[Full Text][Citation analysis]		paper1
2014What Determines the Shape of an EQ-5D Index Distribution? In: Research Papers.
[Full Text][Citation analysis]		paper1
2015An Investigation of the Feasibility and Cultural Appropriateness of Stated Preference Methods to Generate EQ-5D-5L Values in the United Arab Emirates In: Research Papers.
[Full Text][Citation analysis]		paper0
2016Valuing Health-Related Quality of Life: An EQ-5D-5L Value Set for England In: Research Papers.
[Full Text][Citation analysis]		paper30
2018Valuing health‐related quality of life: An EQ‐5D‐5L value set for England.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 30		article
2016New Methods for Modelling EQ-5D-5L Value Sets: An Application to English Data In: Research Papers.
[Full Text][Citation analysis]		paper8
2018New methods for modelling EQ‐5D‐5L value sets: An application to English data.(2018) In: Health Economics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 8		article
2016A Review of NICE Methods Across Health Technology Assessment Programmes: Differences, Justifications and Implications In: Research Papers.
[Full Text][Citation analysis]		paper1
2016The Distribution of the EQ-5D-5L Index in Patient Populations In: Research Papers.
[Full Text][Citation analysis]		paper0
2016Applying a Multi-criteria Decision Analysis (MCDA) Approach to Elicit Stakeholders Preferences in Italy. The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL) In: Research Papers.
[Full Text][Citation analysis]		paper0
2018Applying a Multicriteria Decision Analysis (MCDA) Approach to Elicit Stakeholders’ Preferences in Italy: The Case of Obinutuzumab for Rituximab-Refractory Indolent Non-Hodgkin Lymphoma (iNHL).(2018) In: PharmacoEconomics - Open.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 0		article
2016An Analysis of NICE Technology Appraisal Decisions Recommended in Line with Clinical Practice In: Research Papers.
[Full Text][Citation analysis]		paper0
2017What is the Normative Basis for Selecting the Measure of Average Preferences for Use in Social Choices? In: Research Papers.
[Full Text][Citation analysis]		paper0
2017Comparing the UK EQ-5D-3L and the English EQ-5D-5L Value Sets In: Research Papers.
[Full Text][Citation analysis]		paper2
2018Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets.(2018) In: PharmacoEconomics.
[Full Text][Citation analysis]
This paper has another version. Agregated cites: 2		article
2017Age and Utilities: Issues for HTA In: Research Papers.
[Full Text][Citation analysis]		paper0
2017A New Valuation Method: Directly Eliciting Personal Utility Functions In: Research Papers.
[Full Text][Citation analysis]		paper0
2018New Methods for Analysing the Distribution of EQ-5D Observations In: Research Papers.
[Full Text][Citation analysis]		paper0
2019Can We Really Compare and Aggregate PRO Data Between People and Settings? Implications for Multi-Country Clinical Trials and HTA In: Research Papers.
[Full Text][Citation analysis]		paper0
2019Exploring Variations in the Opportunity Cost Cost-effectiveness Threshold by Clinical Area: Results from a Feasibility Study in England In: Research Papers.
[Full Text][Citation analysis]		paper0
2019Valuing EQ-5D-Y health states using a discrete choice experiment: do adult and adolescent preferences differ? In: Research Papers.
[Full Text][Citation analysis]		paper0
2012Time to tweak the TTO. But how? In: MPRA Paper.
[Full Text][Citation analysis]		paper0
2017EQ-5D and the EuroQol Group: Past, Present and Future In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article3
2017A Review of NICE Methods and Processes Across Health Technology Assessment Programmes: Why the Differences and What is the Impact? In: Applied Health Economics and Health Policy.
[Full Text][Citation analysis]		article2
2013The development of new research methods for the valuation of EQ-5D-5L In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article5
2013The effects of lead time and visual aids in TTO valuation: a study of the EQ-VT framework In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2013Lead versus lag-time trade-off variants: does it make any difference? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article0
2013Time to tweak the TTO: results from a comparison of alternative specifications of the TTO In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2013One-to-one versus group setting for conducting computer-assisted TTO studies: findings from pilot studies in England and the Netherlands In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2017Head-to-head comparison of health-state values derived by a probabilistic choice model and scores on a visual analogue scale In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2018Valuing EQ-5D-5L health states ‘in context’ using a discrete choice experiment In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2019Impact of mapped EQ-5D utilities on cost-effectiveness analysis: in the case of dialysis treatments In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article0
2019A new method for valuing health: directly eliciting personal utility functions In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article1
2005A ‘new and improved’ EQ-5D valuation questionnaire? In: The European Journal of Health Economics.
[Full Text][Citation analysis]		article2
2017Assessing Preference-Based Outcome Measures for Overactive Bladder: An Evaluation of Patient-Reported Outcome Data from the BESIDE Clinical Trial In: The Patient: Patient-Centered Outcomes Research.
[Full Text][Citation analysis]		article0
2010An Analysis of NICE’s ‘Restricted’ (or ‘Optimized’) Decisions In: PharmacoEconomics.
[Full Text][Citation analysis]		article2
2013Operationalizing Value-Based Pricing of Medicines In: PharmacoEconomics.
[Full Text][Citation analysis]		article9
2015A Checklist for Reporting Valuation Studies of Multi-Attribute Utility-Based Instruments (CREATE) In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2018Utility Values for Health States in Ireland: A Value Set for the EQ-5D-5L In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
20183L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2018Correction to: Comparing the UK EQ-5D-3L and English EQ-5D-5L Value Sets In: PharmacoEconomics.
[Full Text][Citation analysis]		article1
2018Correction to: 3L, 5L, What the L? A NICE Conundrum In: PharmacoEconomics.
[Full Text][Citation analysis]		article0
2001Health care spending and economic output: Granger causality In: Applied Economics Letters.
[Full Text][Citation analysis]		article38
2002The Purchasing of Health Care by Primary Care Organisations. An evaluation and Guide to Future Policy, by N. Mays, S. Wyke, G. Malbon, N. Goodwin. Open University Press, Buckingham and Philadelphia, 2 In: Health Economics.
[Full Text][Citation analysis]		article0
2003Logical inconsistencies in survey respondents health state valuations - a methodological challenge for estimating social tariffs In: Health Economics.
[Full Text][Citation analysis]		article8
2004Does NICE have a cost-effectiveness threshold and what other factors influence its decisions? A binary choice analysis In: Health Economics.
[Full Text][Citation analysis]		article89
2004Getting Health Economics into Practice , Edited by David Kernick. Radcliffe Medical Press, Oxford, 2002. No. of pages: 358. ISBN 1-85775-575-8 In: Health Economics.
[Full Text][Citation analysis]		article0
2006A theoretical framework for TTO valuations of health In: Health Economics.
[Full Text][Citation analysis]		article3
2007Is there a case for using visual analogue scale valuations in CUA? Yes there is a case, but what does it add to ordinal data? a rejoinder In: Health Economics.
[Full Text][Citation analysis]		article0
2010Patient‐reported outcome measures in the NHS: new methods for analysing and reporting EQ‐5D data In: Health Economics.
[Full Text][Citation analysis]		article6
2015INTER‐PROVIDER COMPARISON OF PATIENT‐REPORTED OUTCOMES: DEVELOPING AN ADJUSTMENT TO ACCOUNT FOR DIFFERENCES IN PATIENT CASE MIX In: Health Economics.
[Full Text][Citation analysis]		article2

CitEc is a RePEc service, providing citation data for Economics since 2001. Sponsored by INOMICS. Last updated January, 6 2020. Contact: CitEc Team